289 related articles for article (PubMed ID: 33227782)
21. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions.
Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC
Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078
[TBL] [Abstract][Full Text] [Related]
22. The interplay between human papillomavirus and vaginal microbiota in cervical cancer development.
Sharifian K; Shoja Z; Jalilvand S
Virol J; 2023 Apr; 20(1):73. PubMed ID: 37076931
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the Associations Between Cervical Microbiota and HPV Infection, Clearance, and Persistence in Cytologically Normal Women.
Ritu W; Enqi W; Zheng S; Wang J; Ling Y; Wang Y
Cancer Prev Res (Phila); 2019 Jan; 12(1):43-56. PubMed ID: 30463989
[TBL] [Abstract][Full Text] [Related]
24. Role of next-generation sequencing in understanding the interactions between human papillomavirus and the cervicovaginal microbiome.
Cervantes JL; Hong BY
Gynecol Obstet Invest; 2013; 76(4):195-202. PubMed ID: 23711875
[TBL] [Abstract][Full Text] [Related]
25. Vaginosis-associated bacteria and its association with HPV infection.
Romero-Morelos P; Bandala C; Jiménez-Tenorio J; Valdespino-Zavala M; Rodríguez-Esquivel M; Gama-Ríos RA; Bandera A; Mendoza-Rodríguez M; Taniguchi K; Marrero-Rodríguez D; López-Romero R; Ramón-Gallegos E; Salcedo M
Med Clin (Barc); 2019 Jan; 152(1):1-5. PubMed ID: 29544661
[TBL] [Abstract][Full Text] [Related]
26. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling.
Ilhan ZE; Łaniewski P; Thomas N; Roe DJ; Chase DM; Herbst-Kralovetz MM
EBioMedicine; 2019 Jun; 44():675-690. PubMed ID: 31027917
[TBL] [Abstract][Full Text] [Related]
27. A novel sequencing-based vaginal health assay combining self-sampling, HPV detection and genotyping, STI detection, and vaginal microbiome analysis.
Bik EM; Bird SW; Bustamante JP; Leon LE; Nieto PA; Addae K; Alegría-Mera V; Bravo C; Bravo D; Cardenas JP; Carson GA; Caughey A; Covarrubias PC; Pérez-Donoso J; Gass G; Gupta SL; Harman K; Hongo DMB; Jiménez JC; Kraal L; Melis-Arcos F; Morales EH; Morton A; Navas CF; Nuñez H; Olivares E; Órdenes-Aenishanslins N; Ossandon FJ; Phan R; Pino R; Soto-Liebe K; Varas I; Vera-Wolf P; Walton NA; Almonacid DE; Goddard AD; Ugalde JA; Zneimer S; Richman J; Apte ZS
PLoS One; 2019; 14(5):e0215945. PubMed ID: 31042762
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus and cervical cancer in the microbial world: exploring the vaginal microecology.
Zhang Z; Ma Q; Zhang L; Ma L; Wang D; Yang Y; Jia P; Wu Y; Wang F
Front Cell Infect Microbiol; 2024; 14():1325500. PubMed ID: 38333037
[TBL] [Abstract][Full Text] [Related]
29. Vaginal Microbiome Dysbiosis is Associated with the Different Cervical Disease Status.
Ma Y; Li Y; Liu Y; Cao L; Han X; Gao S; Zhang C
J Microbiol; 2023 Apr; 61(4):423-432. PubMed ID: 37010797
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus update with a particular focus on cervical disease.
Garland SM
Pathology; 2002 Jun; 34(3):213-24. PubMed ID: 12109780
[TBL] [Abstract][Full Text] [Related]
31. The vaginal microbiome: A complex milieu affecting risk of human papillomavirus persistence and cervical cancer.
Alimena S; Davis J; Fichorova RN; Feldman S
Curr Probl Cancer; 2022 Aug; 46(4):100877. PubMed ID: 35709613
[TBL] [Abstract][Full Text] [Related]
32. Distribution of the most common types of HPV in Iranian women with and without cervical cancer.
Farahmand Z; Soleimanjahi H; Garshasbi M; Hasanzadeh M; Zafari E
Women Health; 2021 Jan; 61(1):73-82. PubMed ID: 32957835
[TBL] [Abstract][Full Text] [Related]
33. Natural history and epidemiology of HPV infection and cervical cancer.
Castellsagué X
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S4-7. PubMed ID: 18760711
[TBL] [Abstract][Full Text] [Related]
34. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
[TBL] [Abstract][Full Text] [Related]
35. Vaginal microbiome and cervical cancer.
Kyrgiou M; Moscicki AB
Semin Cancer Biol; 2022 Nov; 86(Pt 3):189-198. PubMed ID: 35276341
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
[TBL] [Abstract][Full Text] [Related]
38. Changes in vaginal microbiome after focused ultrasound treatment of high-risk human papillomavirus infection-related low-grade cervical lesions.
Wang W; Liu Y; Yang Y; Ren J; Zhou H
BMC Infect Dis; 2023 Jan; 23(1):3. PubMed ID: 36604622
[TBL] [Abstract][Full Text] [Related]
39. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection.
Di Paola M; Sani C; Clemente AM; Iossa A; Perissi E; Castronovo G; Tanturli M; Rivero D; Cozzolino F; Cavalieri D; Carozzi F; De Filippo C; Torcia MG
Sci Rep; 2017 Aug; 7(1):10200. PubMed ID: 28860468
[TBL] [Abstract][Full Text] [Related]
40. Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy.
Sammarco ML; Del Riccio I; Tamburro M; Grasso GM; Ripabelli G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):222-6. PubMed ID: 23395560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
